XENE - Xenon Pharmaceuticals Inc.
IEX Last Trade
40.12
0 0%
Share volume: 129,398
Last Updated: Tue 24 Dec 2024 06:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.45%
PREVIOUS CLOSE
CHG
CHG%
$40.12
-2.13
0.06%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-08 | 2023-03-01 | 2023-05-09 | 2023-08-09 | |
| Assets | |||||||
| Total Assets | 558.059 M | 807.380 M | 775.813 M | 754.146 M | 719.868 M | 684.899 M | |
| Current Assets | 545.616 M | 794.803 M | 649.176 M | 600.298 M | 533.351 M | 544.616 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.753 M | 4.041 M | 8.509 M | 7.225 M | 4.086 M | 2.893 M | |
| Short Term Investments | 4.753 M | 4.041 M | 8.509 M | 7.225 M | 4.086 M | 2.893 M | |
| Total Receivables | 2.923 M | 2.524 M | 2.482 M | 986.000 K | 2.222 M | 2.123 M | |
| Current Cash | 537.940 M | 788.238 M | 638.185 M | 592.087 M | 527.043 M | 539.600 M | |
| Total Non-current Assets | 12.443 M | 12.577 M | 126.637 M | 153.848 M | 186.517 M | 140.283 M | |
| Property Plant Equipment | 4.336 M | 4.536 M | 4.575 M | 6.500 M | 7.975 M | 9.563 M | |
| Other Assets | 7.900 M | 7.730 M | 7.559 M | 18.157 M | 18.056 M | 17.683 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 558.059 M | 807.380 M | 775.813 M | 754.146 M | 719.868 M | 684.899 M | |
| Total liabilities | 16.206 M | 21.587 M | 22.694 M | 32.649 M | 32.924 M | 38.442 M | |
| Total current liabilities | 7.982 M | 13.736 M | 15.537 M | 22.702 M | 22.491 M | 28.159 M | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 488.000 K | 1.194 M | 1.223 M | |
| Long term debt | 8.224 M | 7.851 M | 7.157 M | 9.947 M | 10.433 M | 10.283 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 541.853 M | 785.793 M | 753.119 M | 721.497 M | 686.944 M | 646.457 M | |
| Common stock | 54.853 M | 56.193 M | 65.465 M | 65.658 M | 65.725 M | 65.861 M | |
| Retained earnings | -377.044 M | -408.202 M | -445.352 M | -482.747 M | -524.474 M | -571.935 M |